ArticleCureus2026
Quantitative Analysis of Vitreo-Macular Adhesion in Diabetic Patients Without Proliferative Retinopathy.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVitreomacular adhesion (VMA) is a physiological stage of posterior vitreous detachment that plays a significant role in the progression of diabetic retinopathy. This study aims to quantitatively assess the percentage of VMA in diabetic patients without proliferative disease compared to non-diabetic controls.
methodsThis is a prospective, double-masked, cross-sectional study conducted at a tertiary eye care center in central India. Consecutive diabetic patients were evaluated. Proliferative diabetic retinopathy (PDR) was excluded. Optical coherence tomography (OCT) of the macula was done using four radial scans (rotational angulation set at 45°, 90°, 135°, and 180°). Patients were classified as either VMA+ or VMA. A quantitative analysis was performed for each case to calculate the percentage length of the retinal surface with attached vitreous cortex (%VMA).
resultsSixty-eight eyes of 40 patients and 50 eyes of 25 age-matched controls were included for analysis. Mean duration of diabetes mellitus (DM) was 7.9 +/-5.4 yrs. 65/68 eyes (96%) of DM group were VMA+, while 42/50 eyes (84%) of the control group were VMA+ (p=0.032), OR=4.12 (CI= 1.03-16.45). Percentage VMA (%VMA) was higher for the DM group at all meridians, but comparison with controls did not reveal statistically significant findings (average %VMA 65% vs. 58%, p=0.251). Though statistically insignificant, the average %VMA was higher for patients with non-proliferative diabetic retinopathy (NPDR; 71%), in comparison to patients without diabetic retinopathy (DR; 63.4%) or with macular edema (61%) (p=0.554).
conclusionWe could not establish a statistically significant quantitative variation of %VMA between diabetic and non-diabetic individuals, or amongst early manifestations of DR. Future studies in advanced stages of DR with upcoming OCT systems are needed to confirm our findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.